A Multicenter Phenotype-Genotype Analysis of LGMD Patients in China

Enrolling by invitationOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

July 7, 2021

Primary Completion Date

July 1, 2026

Study Completion Date

December 1, 2026

Conditions
LGMDLGMDR2LGMDR1
Interventions
DIAGNOSTIC_TEST

Electromyography

Electromyography (EMG) would be used at the baseline for dignoisis and furtue analysis.

DIAGNOSTIC_TEST

IDEAL MRI

Muscle-speciifc sequences (e.g. IDEAL) would be used to scan patients at baseline and follow-up stages to characterize the fat fraction and atrophy in different muscles.

Trial Locations (1)

200040

Huashan Hospital, Shanghai

All Listed Sponsors
lead

Huashan Hospital

OTHER